Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page
- Check5 days agoChange DetectedThe page's revision label changed from v3.6.2 to v3.6.3, indicating a newer revision of the page. This is a minor update applied to the page's underlying revision tag.SummaryDifference0.1%

- Check12 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 to indicate a newer page revision. This change is metadata and does not modify the study content or its presentation.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and displays recruitment status as 'No longer looking for participants'. The Intervention/Treatment heading is updated and the revision footer shows Revision: v3.6.0.SummaryDifference0.4%

- Check33 days agoChange DetectedThe page displays an updated revision label: Revision: v3.5.5, replacing the previous Revision: v3.5.4.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision metadata on the page was updated to v3.5.4, indicating a newer document version and replacing the prior v3.5.3 tag.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page’s software/display footer revision was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.